Illuminant Surgical vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Medical device company projecting CT/MRI anatomy directly onto patients during surgery for real-time guidance; YC-backed $500K raised at $750K-$900K revenue with SIGGRAPH 2025 research presentation.
About
Illuminant Surgical is a medical device company developing Skylight — a real-time anatomical projection system that displays medical imaging data (CT scans, MRI, ultrasound) directly onto the patient's body surface during surgery, giving surgeons continuous visual guidance about subsurface anatomy without looking away from the operative field. Founded in 2022 and backed by Y Combinator with $500,000+ raised from YC, the US National Science Foundation, and angel investors, Illuminant generated $750,000-$900,000 in revenue in 2024 with an 18-person team and presented Skylight research at SIGGRAPH 2025.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.